| Number | Author | Title |
| PC1 | Francesca Arrighi | From Small Molecules to Big Outcomes: Advancing Benzo[b]thiophenes in Neurodegeneration |
| PC2 | Giulia Atzeni | Identification of dual NS3 protease-helicase inhibitors as broad-spectrum antivirals against WNV and ZIKV |
| PC3 | Roberta Bivacqua | Chemical Exploration of N-(2-phenyl-1,3-thiazol-5-yl)benzamides as Inhibitors of Influenza A/H1N1 Hemagglutinin-Mediated Viral Fusion |
| PC4 | Fernando Cagide-Fagín | Hydroxypyridin-4-one-based ligands as multifunctional therapeutics for neurodegenerative diseases |
| PC5 | Michele Coluccia | Novel Benzofuran-Donepezil derivatives to dually inhibit monoamine oxidases and cholinesterases: a multifunctional strategy against neurodegenerative diseases |
| PC6 | Chaimae El Hadri | Targeting CtBP Mediated Oncogenic Transcriptional Activity With Structure Guided Ligand |
| PC7 | Elsi Ferro | Integrated Experimental and Computational Analysis of Benzimidazole α-Glucosidase Inhibitors for Pathway-Informed Design |
| PC8 | Ilario Greco | In Silico Screening of Natural Product Libraries for α-Glucosidase Inhibitors Targeting Saccharomyces cerevisiae |
| PC9 | Alessandro Gualtieri | Phosphorite: useful industrial waste for one-pot green synthesis of quinolones |
| PC10 | Gyde Bandowski | Synthesis of γ-monoalkylated Triphosphate Analogues to inhibit SARS-CoV-2 Replication-Transcription Complex |
| PC11 | Michał Jastrzębski | Synthesis, molecular modeling and assessment of anticancer activity of new CYP17A1 inhibitors of the D2AAK1M series |
| PC12 | Radomir Juza | A novel cariprazine-derived D2/5-HT3 receptor modulators with potential implications for the treatment of schizophrenia and depressive symptoms |
| PC13 | Jan Konecny | Optimization of pyrrolo[3,2-d]pyrimidine derivatives as antitubercular agents through drug-driven design |
| PC14 | Violetta Krajka-Kuźniak | 20-Hydroxyecdysone modulates inflammatory cytokines in human psoriatic keratinocytes, PHEK cells |
| PC15 | Martin Kratky | 3,5-Diiodosalicylaldehyde: A Valuable Building Block for Novel Antifungal Agents |
| PC16 | Valeria La Gatta | Characterization of human thymidylate synthase dimer disruptor interactions by photoaffinity labeling |
| PC17 | Lara Prilop | Combining DHODH inhibitors and pronucleotides to block viral replication |
| PC18 | Laura Gabriela Sarbu | Novel tricyclic flavonoids as promising anti-MRSA agents |
| PC19 | Antonio Laus | A Bayesian-optimized, shape-driven oneOPES framework for resolving membrane-dependent nucleation landscapes of human IAPP toward mechanism-guided design |
| PC20 | Inês Lima | Bioisosteric replacement of the maleimide warhead in a selective covalent NOX4 inhibitor |
| PC21 | Andrea Mancini | From Fragments to Leads: Design and Synthesis of High-Affinity Sirtuin 6 Inhibitors via Structure-Guided Optimization |
| PC22 | Emanuela Marchese | Deciphering the impact of phosphorylation on HuR functional domains through molecular dynamics simulations |
| PC23 | Eva Mezeiova | Substituted cinnamylpiperazines as modulators of AcrAB-TolC-mediated antibiotic resistance |
| PC24 | Mihail Lucian Birsa | Synthetic flavonoid – an alternative solution to combat eskape pathogens |
| PC25 | Joana Moreira | Nanostructured Liposomal Systems for Safer Delivery of Triphenylphosphonium Derivatives |
| PC26 | Adam Anthony Needle | Replacement of the Nitrile with Boronic Acid in Second-Generation Anti-androgen Enzalutamide: Design and Synthesis |
| PC27 | Alessia Onali | Dual Targeting of hCAIX and STAT3 by a Novel Small Molecule Synergizes with Doxorubicin to Induce Apoptosis in Hypoxic Glioblastoma Cells |
| PC28 | Maria Rosaria Paravati | From Viral Proteins to Host Targets: Unveiling Casein Kinase 2 as the Antiviral Mechanism of the [4,7]-Phenanthroline Scaffold |
| PC29 | Ludwika Piwowarczyk | Nanocarrier-based delivery of 20-hydroxyecdysone modulates IL-17/IL-23 signaling in psoriasis model |
| PC30 | Teresa Rocha | Balancing the potency and toxicity of novel antimicrobial agents by rational design |
| PC31 | Erica Sanna | The Coronavirus Helicase as a Drug Target: New Chemical Approaches Against a Conserved Viral Engine |
| PC32 | Denisa Sarova | Discovery of Novel FLT3-Tyrosine Kinase Inhibitors for the Treatment of Acute Myeloid Leukemia |
| PC33 | Rosa Scarpelli | Deep Eutectic Solvents (DES) for the Sustainable Extraction of Phytocompounds from Cannabis sativa |
| PC34 | Lisa Sequeira | Polymerization-induced self-assembly of ROS-sensitive nanovesicles for dual-drug delivery in ALS therapy |
| PC35 | Barbora Svobodova | A Novel FLT3-Targeted Strategy to Overcome Drug Resistance in Acute Myeloid Leukemia |
| PC36 | Jagoda Szkudlarek | Cationic Liposomes Co-Loaded With Cannabidiol and Additional Natural Bioactive Compounds for In Vitro Evaluation Against Glioblastoma Multiforme |
| PC37 | Jagoda Szkudlarek | Hydration Medium Matters: Development and Physicochemical Evaluation of 20-Hydroxyecdysone Niosomes for Topical Psoriasis Treatment |
| PC38 | Terezia Teplanova | Development of fluorinated triazinoindoles as highly potent and markedly selective aldose reductase inhibitors focused on prevention of diabetic complications |
| PC39 | Angela Vavalà | Accurate profiling of EVOO secoiridoids for EFSA health claim validation: comparing UHPLC-ESI-HRMS approach against official methods |
| PC40 | Joanna Izabela Lachowicz | Thymosin β4 as a Metal‑Responsive Regulator of Ferroptosis and Cellular Stress: Implications for Medicinal Chemistry |
